Monthly Archives: March 2020

Newsletter, MARCH 2020

30th March 2020  Newsletter March 2020  News New Publication: The Lancet Haematology Journal The results of DEEP-2 study have been accepted for publication on The Lancet Haematology Journal. DEEP-2 is one of three studies foreseen in the DEEP (DEferiprone Evaluation in Paediatrics) project, a 6-year European Project (FP7) coordinated by CVBF.  Read more New Publication [...]

By |2023-11-24T09:58:03+00:00March 30th, 2020|Newsletter|

SAVE THE DATE. EPTRI Virtual Meeting, 2-3 April 2020

Due to the progress of the situation related to the new coronavirus infection and the declaration of the pandemic status by the WHO, the management team analysed the practicability to organise the EPTRI Open Meeting on the 2nd and 3rd of April 2020 in Brussels. To guarantee the safely participation of everybody and the contribution to this crucial [...]

By |2020-03-30T07:20:06+00:00March 27th, 2020|News|

SAVE THE DATE. EUCROF Webinar: Traceability in Clinical Trials: Challenges of the new EU TMF/eTMF Guideline

The EUCROF Events&Training Working Group, which Chair is our CEO Dr Donato Bonifazi, presents the webinar “Traceability in Clinical Trials: Challenges of the new EU TMF/eTMF Guideline” that will be held on 28 April 2020 (from 10:00 to 11:30 CET). The webinar offers an overview of the EU Guideline on electronic Trial Master File (eTMF) [...]

By |2020-04-02T10:29:38+00:00March 26th, 2020|News|

ER ICU. COVID-19 Dataset

Since the terrible stress upon hospitals and ICUs is one of the greatest challenges the disease created, and for now possibly the most crucial point for saving life, once a person gets ill, The State of Israel is establishing a central data center, where medical electronic records (ER) of the COVID-19 patients, and particularly the [...]

By |2020-04-02T10:41:49+00:00March 26th, 2020|News|

COVID-19: what is the current situation of the International Authorities

A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organisation Country Office in China on 31 December 2019. After just three months WHO characterised COVID-19 as pandemic, currently affecting 157 countries and territories around the world. Besides the impact on international financial market and individual social life, COVID-19 [...]

By |2020-04-02T10:43:23+00:00March 26th, 2020|News|

EMA public engagement highlights: an overview on activities in 2019

On March 2020, the European Medicines Agency released its annual overview of the involvement of patients and healthcare professionals in the work of the Agency. The report underlined a high percentage (90%) of cases, in which coordinators of scientific advice procedures considered patient involvement as a key action in their decision-making process. Several events have [...]

By |2020-04-02T10:49:06+00:00March 26th, 2020|News|

Italian Web Portal on Rare Diseases

The Italian Ministry of Health presented the new website www.malattierare.gov.it dedicated to rare diseases to collect all the reference points on the Italian territory for rare patients. It is estimated that over one million rare patients live in Italy, while around 325 thousand patients are registered in the National Register of Rare Diseases, which reports [...]

By |2020-04-02T10:53:26+00:00March 26th, 2020|News|

HEPATOMICS: CVBF will contribute to the new project selected by the Cypriot Research Promotion Foundation

The Cypriot Research Promotion Foundation (RPF) selected for funding the project “HEPATOMICS”, aimed to identify novel peripheral blood biomarkers for liver damage in b-thalassaemia through the use of “omics” technologies. β-thalassaemia is a hereditary haemoglobinopathy caused by reduced or absent expression of β-globin. In its most serious form, it leads to severe anaemia and related [...]

By |2020-04-02T11:10:11+00:00March 26th, 2020|News|

CVBF is involved in the multinational clinical study SAIL

SAIL is an observational study to assess the effectiveness, safety profile and real-life prescribing and utilization patterns of a monoclonal antibody in patients with moderate to severe plaque psoriasis in routine clinical practice. Psoriasis affects an estimated 7.8 million adults in Europe and approximately 125 million individuals worldwide, according to the release. Plaque psoriasis appears [...]

By |2020-04-02T11:15:10+00:00March 26th, 2020|News|

A new project for CVBF: SINERGY – Toward extracellular vesicle-based therapeutics for the treatment of bronchopulmonary dysplasia

Fondazione Città della Speranza-Onlus awarded the project “SYNERGY - toward extracellular vesicle-based therapeutics for the treatment of bronchopulmonary dysplasia”. The project, started in 2019, aims to fill in the pre-clinical gaps required to allow the clinical application of extracellular vescicles (EVs) for the treatment of Bronchopulmonary dysplasia (BPD). In particular, the project, that lasts two [...]

By |2020-04-02T11:18:23+00:00March 26th, 2020|News|

Newsletter

Sign-up to get the latest news and update information. Don’t worry, we won’t send spam!

Go to Top